Dataset Information

Compliance with medical recommendations depending on the use of artificial intelligence as a diagnostic method.

ABSTRACT:

Background

Advanced analytics, such as artificial intelligence (AI), increasingly gain relevance in medicine. However, patients' responses to the involvement of AI in the care process remains largely unclear. The study aims to explore whether individuals were more likely to follow a recommendation when a physician used AI in the diagnostic process considering a highly (vs. less) severe disease compared to when the physician did not use AI or when AI fully replaced the physician.

Methods

Participants from the USA (n = 452) were randomly assigned to a hypothetical scenario where they imagined that they received a treatment recommendation after a skin cancer diagnosis (high vs. low severity) from a physician, a physician using AI, or an automated AI tool. They then indicated their intention to follow the recommendation. Regression analyses were used to test hypotheses. Beta coefficients (ß) describe the nature and strength of relationships between predictors and outcome variables; confidence intervals [CI] excluding zero indicate significant mediation effects.

Results

The total effects reveal the inferiority of automated AI (ß = .47, p = .001 vs. physician; ß = .49, p = .001 vs. physician using AI). Two pathways increase intention to follow the recommendation. When a physician performs the assessment (vs. automated AI), the perception that the physician is real and present (a concept called social presence) is high, which increases intention to follow the recommendation (ß = .22, 95% CI [.09; 0.39]). When AI performs the assessment (vs. physician only), perceived innovativeness of the method is high, which increases intention to follow the recommendation (ß = .15, 95% CI [- .28; - .04]). When physicians use AI, social presence does not decrease and perceived innovativeness increases.

Conclusion

Pairing AI with a physician in medical diagnosis and treatment in a hypothetical scenario using topical therapy and oral medication as treatment recommendations leads to a higher intention to follow the recommendation than AI on its own. The findings might help develop practice guidelines for cases where AI involvement benefits outweigh risks, such as using AI in pathology and radiology, to enable augmented human intelligence and inform physicians about diagnoses and treatments.

SUBMITTER: Soellner M

PROVIDER: S-EPMC8344186 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:BackgroundThe COVID-19 pandemic has limited daily activities and even contact between patients and primary care providers. This makes it more difficult to provide adequate primary care services, which include connecting patients to an appropriate medical specialist. A smartphone-compatible artificial intelligence (AI) chatbot that classifies patients' symptoms and recommends the appropriate medical specialty could provide a valuable solution.ObjectiveIn order to establish a contactless method of recommending the appropriate medical specialty, this study aimed to construct a deep learning-based natural language processing (NLP) pipeline and to develop an AI chatbot that can be used on a smartphone.MethodsWe collected 118,008 sentences containing information on symptoms with labels (medical specialty), conducted data cleansing, and finally constructed a pipeline of 51,134 sentences for this study. Several deep learning models, including 4 different long short-term memory (LSTM) models with or without attention and with or without a pretrained FastText embedding layer, as well as bidirectional encoder representations from transformers for NLP, were trained and validated using a randomly selected test data set. The performance of the models was evaluated on the basis of the precision, recall, F1-score, and area under the receiver operating characteristic curve (AUC). An AI chatbot was also designed to make it easy for patients to use this specialty recommendation system. We used an open-source framework called "Alpha" to develop our AI chatbot. This takes the form of a web-based app with a frontend chat interface capable of conversing in text and a backend cloud-based server application to handle data collection, process the data with a deep learning model, and offer the medical specialty recommendation in a responsive web that is compatible with both desktops and smartphones.ResultsThe bidirectional encoder representations from transformers model yielded the best performance, with an AUC of 0.964 and F1-score of 0.768, followed by LSTM model with embedding vectors, with an AUC of 0.965 and F1-score of 0.739. Considering the limitations of computing resources and the wide availability of smartphones, the LSTM model with embedding vectors trained on our data set was adopted for our AI chatbot service. We also deployed an Alpha version of the AI chatbot to be executed on both desktops and smartphones.ConclusionsWith the increasing need for telemedicine during the current COVID-19 pandemic, an AI chatbot with a deep learning-based NLP model that can recommend a medical specialty to patients through their smartphones would be exceedingly useful. This chatbot allows patients to identify the proper medical specialist in a rapid and contactless manner, based on their symptoms, thus potentially supporting both patients and primary care providers.

Project description:Introduction: Accurate and rapid diagnostics paired with effective tracking and tracing systems are key to halting the spread of infectious diseases, limiting the emergence of new variants and to monitor vaccine efficacy. The current gold standard test (RT-qPCR) for COVID-19 is highly accurate and sensitive, but is time-consuming, and requires expensive specialised, lab-based equipment. Methods: Herein, we report on the development of a SARS-CoV-2 (COVID-19) rapid and inexpensive diagnostic platform that relies on a reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay and a portable smart diagnostic device. Automated image acquisition and an Artificial Intelligence (AI) deep learning model embedded in the Virus Hunter 6 (VH6) device allow to remove any subjectivity in the interpretation of results. The VH6 device is also linked to a smartphone companion application that registers patients for swab collection and manages the entire process, thus ensuring tests are traced and data securely stored. Results: Our designed AI-implemented diagnostic platform recognises the nucleocapsid protein gene of SARS-CoV-2 with high analytical sensitivity and specificity. A total of 752 NHS patient samples, 367 confirmed positives for coronavirus disease (COVID-19) and 385 negatives, were used for the development and validation of the test and the AI-assisted platform. The smart diagnostic platform was then used to test 150 positive clinical samples covering a dynamic range of clinically meaningful viral loads and 250 negative samples. When compared to RT-qPCR, our AI-assisted diagnostics platform was shown to be reliable, highly specific (100%) and sensitive (98-100% depending on viral load) with a limit of detection of 1.4 copies of RNA per µL in 30 min. Using this data, our CE-IVD and MHRA approved test and associated diagnostic platform has been approved for medical use in the United Kingdom under the UK Health Security Agency's Medical Devices (Coronavirus Test Device Approvals, CTDA) Regulations 2022. Laboratory and in-silico data presented here also indicates that the VIDIIA diagnostic platform is able to detect the main variants of concern in the United Kingdom (September 2023). Discussion: This system could provide an efficient, time and cost-effective platform to diagnose SARS-CoV-2 and other infectious diseases in resource-limited settings.

Project description:BackgroundProspective physicians are expected to find artificial intelligence (AI) to be a key technology in their future practice. This transformative change has caught the attention of scientists, educators, and policy makers alike, with substantive efforts dedicated to the selection and delivery of AI topics and competencies in the medical curriculum. Less is known about the behavioral perspective or the necessary and sufficient preconditions for medical students' intention to use AI in the first place.ObjectiveOur study focused on medical students' knowledge, experience, attitude, and beliefs related to AI and aimed to understand whether they are necessary conditions and form sufficient configurations of conditions associated with behavioral intentions to use AI in their future medical practice.MethodsWe administered a 2-staged questionnaire operationalizing the variables of interest (ie, knowledge, experience, attitude, and beliefs related to AI, as well as intention to use AI) and recorded 184 responses at t0 (February 2020, before the COVID-19 pandemic) and 138 responses at t1 (January 2021, during the COVID-19 pandemic). Following established guidelines, we applied necessary condition analysis and fuzzy-set qualitative comparative analysis to analyze the data.ResultsFindings from the fuzzy-set qualitative comparative analysis show that the intention to use AI is only observed when students have a strong belief in the role of AI (individually necessary condition); certain AI profiles, that is, combinations of knowledge and experience, attitudes and beliefs, and academic level and gender, are always associated with high intentions to use AI (equifinal and sufficient configurations); and profiles associated with nonhigh intentions cannot be inferred from profiles associated with high intentions (causal asymmetry).ConclusionsOur work contributes to prior knowledge by showing that a strong belief in the role of AI in the future of medical professions is a necessary condition for behavioral intentions to use AI. Moreover, we suggest that the preparation of medical students should go beyond teaching AI competencies and that educators need to account for the different AI profiles associated with high or nonhigh intentions to adopt AI.

Project description:Background and Purpose Chronic obstructive pulmonary disease (COPD), is a primary public health issue globally and in our country, which continues to increase due to poor awareness of the disease and lack of necessary preventive measures. COPD is the result of a blockage of the air sacs known as alveoli within the lungs; it is a persistent sickness that causes difficulty in breathing, cough, and shortness of breath. COPD is characterized by breathing signs and symptoms and airflow challenge because of anomalies in the airways and alveoli that occurs as the result of significant exposure to harmful particles and gases. The spirometry test (breath measurement test), used for diagnosing COPD, is creating difficulties in reaching hospitals, especially in patients with disabilities or advanced disease and in children. To facilitate the diagnostic treatment and prevent these problems, it is far evaluated that using photoplethysmography (PPG) signal in the diagnosis of COPD disease would be beneficial in order to simplify and speed up the diagnosis process and make it more convenient for monitoring. A PPG signal includes numerous components, including volumetric changes in arterial blood that are related to heart activity, fluctuations in venous blood volume that modify the PPG signal, a direct current (DC) component that shows the optical properties of the tissues, and modest energy changes in the body. PPG has typically received the usage of a pulse oximeter, which illuminates the pores and skin and measures adjustments in mild absorption. PPG occurring with every heart rate is an easy signal to measure. PPG signal is modeled by machine learning to predict COPD. Methods During the studies, the PPG signal was cleaned of noise, and a brand-new PPG signal having three low-frequency bands of the PPG was obtained. Each of the four signals extracted 25 features. An aggregate of 100 features have been extracted. Additionally, weight, height, and age were also used as characteristics. In the feature selection process, we employed the Fisher method. The intention of using this method is to improve performance. Results This improved PPG prediction models have an accuracy rate of 0.95 performance value for all individuals. Classification algorithms used in feature selection algorithm has contributed to a performance increase. Conclusion According to the findings, PPG-based COPD prediction models are suitable for usage in practice.